KW-0761

mogamulizumab · Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for KW-0761, covering 2012-09-07 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy [Phase 4]

See pricing